Doctors may soon be able to detect and monitor a patient’s cancer with a simple blood test, reducing or eliminating the need for more invasive procedures, according to Purdue University research.
W. Andy Tao, a professor of biochemistry and member of the Purdue University Center for Cancer Research and colleagues identified a series of proteins in blood plasma that, when elevated, signify that the patient has cancer. Their findings were published in the early edition of the Proceedings of the National Academy of Sciences.
Tao’s work was done with samples from breast cancer patients, but it is possible the method could work for any type of cancer and other types of diseases. The work relies on analysis of microvesicles and exosomes in blood plasma.
Protein phosphorylation, the addition of a phosphate group to a protein can lead to cancer cell formation. So phosphorylated proteins, known as phosphoproteins, have been seen as prime candidates for cancer biomarkers. Until now, however, scientists weren’t sure identification of phosphoproteins in blood was possible because the liver releases phosphatase into the bloodstream, which dephosphorylates proteins.
“There are so many types of cancer, even multiple forms for different types of cancer, that finding biomarkers has been discouraging,” Tao said. “This is definitely a breakthrough, showing the feasibility of using phosphoproteins in blood for detecting and monitoring diseases.”
Tao and his colleagues found nearly 2,400 phosphoproteins in a blood sample and identified 144 that were significantly elevated in cancer patients. The study compared 1-milliliter blood samples from 30 breast cancer patients with six healthy controls.
The researchers used centrifuges to separate plasma from red blood cells, and high-speed and ultra-high-speed centrifuges to further separate microvesicles and exosomes. Those particles, which are released from cells and enter the bloodstream, may play a role in intercellular communication and are thought to be involved in metastasis, spreading cancer from one place to another in the body. They also encapsulate phosphoproteins, which Tao’s team identified using mass spectrometry.
“Extracellular vesicles, which include exosomes and microvesicles, are membrane-encapsulated. They are stable, which is important,” Tao said. “The samples we used were 5 years old, and we were still able to identify phosphoproteins, suggesting this is a viable method for identifying disease biomarkers.”
A simple blood test for cancer would be far less invasive than scopes or biopsies that remove tissue. A doctor could also regularly test a cancer patient’s blood to understand the effectiveness of treatment and monitor patients after treatment to see if the cancer is returning.
“There is currently almost no way to monitor patients after treatment,” Tao said. “Doctors have to wait until cancer comes back.”
Timothy Ratliff, director of the Purdue University Center for Cancer Research, said the findings are promising for early detection of cancer.
“The vesicles and exosomes are present and released by all cancers, so it could be that there are general patterns for cancer tissues, but it’s more likely that Andy will develop patterns associated with different cancers. It’s really exciting,” Ratliff said. “Early detection in cancer is key and has been shown to clearly reduce the death rate associated with the disease.”
Tao plans to analyze increased levels of phosphoproteins in various types of cancer to determine whether there are patterns that would signify the type of cancer a patient has. His company, Tymora Analytical, is also developing technology that would allow doctors to insert blood samples onto a cartridge and analyze phosphoproteins present, eliminating the need for ultra-high-speed centrifuges that aren’t practical in clinical settings.
Learn more: Breakthrough discovery may make blood test feasible for detecting cancer
[osd_subscribe categories=’cancer-blood-test’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “CANCER BLOOD TEST”‘]
Receive an email update when we add a new CANCER BLOOD TEST article.
The Latest on: Cancer blood test
[google_news title=”” keyword=”cancer blood test” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer blood test
- ‘Healthy’ woman, 32, riddled with cancer stuns doctors when they discover surprising first symptomon May 2, 2024 at 3:22 pm
When signs do appear they may include: A cough that lasts three weeks or more, and may hurt Repeated chest infections Coughing up blood Breathlessness Unusual tiredness The NHS does not routinely ...
- Mom went to hospital for blindness — discovered she had lung canceron May 2, 2024 at 10:56 am
Tests revealed that she had lung cancer along with choroidal metastasis in both of her eyes. Choroidal metastasis is a cancer that starts elsewhere in the body but moves into the eyes via the blood, ...
- Testing for residual cancer cells before blood cell transplant therapy is important and practical, new study findson May 2, 2024 at 8:01 am
Patients in remission after battling a high-risk blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells.
- You Can Test Your Blood for 50 Kinds of Canceron May 2, 2024 at 7:50 am
According to its website, the Menlo Park–based firm got its name because its “co-founders believed a simple blood test could be the ‘holy GRAIL’ of cancer detection.” Now the company claims that its ...
- Stomach cancer – symptoms, causes and treatmenton May 2, 2024 at 5:00 am
Stomach cancer, also known as gastric cancer, is the fourth-highest cause of cancer deaths worldwide, and 17th-most common cancer in the UK. According to Cancer Research UK, cases of stomach cancer in ...
- Khosla, VCs Plow $100 Million Into Blood Test Startup Using AIon May 2, 2024 at 5:00 am
Blood-testing company Karius Inc. raised $100 million in a new funding round from investors, and will use the cash to get its technology for detecting hard-to-identify infections into more hospitals.
- Could blood tests make early stage cancer diagnosis accessible?on May 2, 2024 at 12:55 am
A U.S. company is developing a blood test to detect 18 types of cancers. But there is still work ahead to prove its value.
- Novel Blood Biomarkers Show Potential for Early Liver Cancer Diagnosison May 1, 2024 at 5:00 pm
A total of 56 elevated proteins were identified in the HCC cohort compared with matched controls without HCC, with an absolute fold-change greater than 1.2 and a conditional regression analysis Wald ...
- Dallas’ Breakthrough Blood Test for Canceron April 30, 2024 at 7:18 pm
A North Dallas diagnostic firm may be on the verge of revolutionizing the cancer screening process. Cancer Check Labs has developed a technology that can screen 40ml of blood and detect the growth of ...
via Bing News